Samsung Biologics is virtually participating in the 39th annual J.P Morgan Healthcare Conference, taking place from the 11th to Jan 14th this year. The conference aims to feature leading innovators worldwide to address arising health challenges and share ideas and solutions to reshape future wellness.
This year will be Samsung Biologics' fifth year to present at the event's main track session. John Rim, the Company's newly appointed CEO, is scheduled to share the Company's vision, insight, and future investments for the next decade on Wednesday this week, Jan 13th.
Samsung Biologics will also be available at the BIO One-on-One Partnering to discuss effective ways to expedite successful processes to deliver innovative solutions to the health industry.
Samsung Biologics is virtually participating in the 39th annual J.P Morgan Healthcare Conference, taking place from the 11th to Jan 14th this year. The conference aims to feature leading innovators worldwide to address arising health challenges and share ideas and solutions to reshape future wellness.
This year will be Samsung Biologics' fifth year to present at the event's main track session. John Rim, the Company's newly appointed CEO, is scheduled to share the Company's vision, insight, and future investments for the next decade on Wednesday this week, Jan 13th.
Samsung Biologics will also be available at the BIO One-on-One Partnering to discuss effective ways to expedite successful processes to deliver innovative solutions to the health industry.